NCT05717790 2023-02-08
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Fourth Affiliated Hospital of Guangxi Medical University
Phase NA Recruiting
Clinical Trials
3 trialsNCT05352321 2022-07-01
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase NA Recruiting
NCT02627807 2020-06-16
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase NA Unknown